Histone deacetylase 10-promoted autophagy as a druggable point of interference to improve the treatment response of advanced neuroblastomas

Autophagy

Volumn 9, Issue 12, 2013, Pages 2163-2165

  Oehme, Ina ^a   Lodrini, Marco ^a   Brady, Nathan R ^b   Witt, Olaf ^a,c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Drug resistance; HDAC inhibitor; HDAC10; Lysosome; Macroautophagy; Neuroblastoma

Indexed keywords

HISTONE DEACETYLASE; HISTONE DEACETYLASE 10; ISOENZYME; UNCLASSIFIED DRUG;

AUTOPHAGY; CELL SURVIVAL; CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; NEUROBLASTOMA; NEUROBLASTOMA CELL; PROMOTER REGION; SHORT SURVEY; TREATMENT RESPONSE;

DRUG RESISTANCE; HDAC-INHIBITOR; HDAC10; LYSOSOME; MACROAUTOPHAGY; NEUROBLASTOMA;

ANTINEOPLASTIC AGENTS; AUTOPHAGY; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HUMANS; MOLECULAR TARGETED THERAPY; NEUROBLASTOMA; TREATMENT OUTCOME;

EID: 84890845105     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.26450     Document Type: Short Survey

References (0)